StonvexLoading…
StonvexStonvexStonvexCore line items from TSQ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $115.88M | $96.78M | $427.38M | $320.88M | $214.12M |
Operating Income | Not available | $-1.27M | $44.20M | $34.12M | $28.18M |
Net Income | Not available | $2.77M | $-11.52M | $-6.32M | $-415.00K |
EPS (Diluted) | $0.19 | $0.16 | $-0.71 | $-0.39 | $-0.03 |
Total Assets | Not available | $516.06M | $528.62M | $539.23M | $545.73M |
Total Liabilities | Not available | $552.30M | $569.61M | $573.20M | $572.82M |
Cash & Equivalents | Not available | $2.18M | $4.76M | $3.21M | $3.18M |
Free Cash Flow OCF − CapEx | Not available | $558.00K | $15.38M | $6.19M | $1.86M |
Shares Outstanding | Not available | 17.72M | 16.18M | 16.14M | 16.06M |